Gianfranco Piccirillo

Prof. Dr. Gianfranco Piccirillo

Department of Internal and Clinical Medicine, Anesthesiology and Cardiovascular Sciences, “Sapienza” University of Rome, 00186 Rome, Italy
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2007 in European Heart Journal
Verified
Journal Article
Closed access
PDF file
Gianfranco PiccirilloGianfranco Piccirillo
Gianfranco Piccirillo
DMDamiano Magrì
Damiano Magrì
SMSabrina Matera
Sabrina Matera
MMMarzia Magnanti
Marzia Magnanti
ATAlessia Torrini
Alessia Torrini
FBFrancesco Barillà
Francesco Barillà
Aims The most widely accepted marker for stratifying the risk of sudden cardiac death (SCD) in post myocardial infarction patients is a depressed left ventricular function. Left ventricular ejection fractions (EF) of 35% or less increase the risk of sudden death but values between 35 and 40% raise concern. The underlying pathophysiological mechanism is sustained ventricular tachycardia or fibrillation, both associated with increased cardiac repolarization variability. We assessed whether the indices of QT variability from a short-term electrocardiographic (ECG) recording predict sudden death.

1 April 2009 in Heart Rhythm
Verified
Journal Article
Closed access
Gianfranco PiccirilloGianfranco Piccirillo
Gianfranco Piccirillo
MOMasahiro Ogawa
Masahiro Ogawa
JSJuan Song
Juan Song
VCVoon J. Chong
Voon J. Chong
BJBo Young Joung
Bo Young Joung
PCPeng-Sheng Chen
Peng-Sheng Chen

1 August 2009 in JACC
Verified
Journal Article
Closed access
Gianfranco PiccirilloGianfranco Piccirillo
Gianfranco Piccirillo
DMDamiano Magrì
Damiano Magrì
MOMasahiro Ogawa
Masahiro Ogawa
JSJuan Song
Juan Song
VCVoon J. Chong
Voon J. Chong
PCPeng-Sheng Chen
Peng-Sheng Chen

1 August 2006 in Translational Research
Verified
Journal Article
Closed access
Gianfranco PiccirilloGianfranco Piccirillo
Gianfranco Piccirillo
MMMarzia Magnanti
Marzia Magnanti
SMSabrina Matera
Sabrina Matera
SCSilvia Di Carlo
Silvia Di Carlo
TLTiziana De Laurentis
Tiziana De Laurentis
DMDamiano Magrì
Damiano Magrì

1 November 2002 in The American Journal of Cardiology
Verified
Journal Article
Closed access
Gianfranco PiccirilloGianfranco Piccirillo
Gianfranco Piccirillo
RQRaffaele Quaglione
Raffaele Quaglione
MNMarialuce Nocco
Marialuce Nocco
CNCamilla Naso
Camilla Naso
AMAntonio Moisè
Antonio Moisè
VMVincenzo Marigliano
Vincenzo Marigliano

1 June 2003 in Hypertension
Verified
Journal Article
Closed access
Gianfranco PiccirilloGianfranco Piccirillo
Gianfranco Piccirillo
MNMarialuce Nocco
Marialuce Nocco
AMAntonio Moisè
Antonio Moisè
MLMarco Lionetti
Marco Lionetti
CNCamilla Naso
Camilla Naso
VMVincenzo Marigliano
Vincenzo Marigliano
Chronic heart failure (CHF) reduces baroreflex sensitivity. Low baroreflex sensitivity, a risk factor for sudden death, could arise partly from CHF-dependent endothelial dysfunction. Vitamin C at high doses has a protective role against CHF-related endothelial damage. This study was conducted to investigate the effect of vitamin C on baroreflex sensitivity in CHF. A study group of 33 subjects with CHF secondary to postischemic dilated cardiomyopathy with an ejection fraction ≤35% and a control group (11 subjects) underwent assessment of baroreflex sensitivity by the phenylephrine method and an autonomic nervous system study by power spectral analysis. Variables were assessed after infusion of placebo and high doses of vitamin C (2.5 mg). In subjects with CHF, baroreflex sensitivity was significantly higher after vitamin C than after placebo infusion (placebo: 4.1±0.4 versus vitamin C: 5.3±0.5 ms/mm Hg, P <0.001). Low-frequency of R-R (LF RR ), expressed in normalized units (NU) ( P <0.05); LF/high-frequency (HF) ratio ( P <0.05), and LF of SBP (LF SBP ) decreased significantly; HF power ( P <0.05), and α-HF ( P <0.001) increased. Conversely, in the control group, baroreflex sensitivity and other spectral variables measured at baseline, after placebo, and after vitamin C infusion remained statistically unchanged (placebo: 10.2±0.1 versus vitamin C: 10.0±0.2 ms/mm Hg, NS). Acute administration of vitamin C at high doses improves baroreflex sensitivity and vagal sinus modulation in patients with CHF. This finding could have notable clinical and therapeutic implications. Key issues to understand are whether the beneficial effect persists during chronic administration and whether it helps to improve survival.